Quote:
Originally Posted by unsunghero
[You must be logged in to view images. Log in or Register.]
Any other exaggerated concerns that don’t actually apply the the majority of people on these meds?
|
Akathisia is another common EPS. 32, 46, 53-55 Akathisia is distinct in being defined by subjective as well as objective features, more often affecting the lower extremities, remaining a problem even with SGAs, and being less responsive to treatment. Subjectively, patients complain of inner tension, restlessness, anxiety, urge to move and inability to sit still, and drawing sensations in the legs. Observable motor features are complex, semi-purposeful and repetitive, including foot shuffling or tapping, shifting of weight, rocking, pacing incessantly and even running. Although the severity of these sensations varies with stress and arousal, they can become intolerable and have been associated with violence and suicide
Akathisia may begin within several days after treatment but usually increases with duration of treatment, occurring in up to 50% of cases within one month and 90% of cases within three months. 32 Akathisia should resolve after drug discontinuation, but could temporarily worsen or persist in withdrawal or tardive forms.